Form 4: CareDx CEO Sells Shares Under Pre-Arranged 10b5-1 Plan

CareDx, Inc. President and CEO, John Walter Hanna Jr., sold 21,998 shares of common stock for approximately $24.02 per share under a pre-arranged trading plan.

Summary

• John Walter Hanna Jr., President and CEO of CareDx, Inc. (CDNA), reported the sale of common stock.
• The transaction involved 21,998 shares of CareDx common stock.
• The shares were sold on June 11, 2026, at a weighted average price of $24.0223 per share.
• The total value of the sale was approximately $528,410.05.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hanna on December 13, 2024.
• Following this transaction, Mr. Hanna directly beneficially owns 649,642 shares of CareDx common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. While it is an insider sale, the execution under a pre-arranged 10b5-1 plan mitigates concerns about its implications for the company's immediate prospects, suggesting personal financial planning rather than a reaction to new information.

Positives

• The sale was executed under a pre-arranged Rule 10b5-1 trading plan, which indicates a planned personal financial management strategy rather than a reaction to new, non-public information.

Negatives

• An insider sale, even under a 10b5-1 plan, represents a reduction in the executive's direct ownership stake in the company.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 trading plans are common for executives managing personal finances and are generally less indicative of management's sentiment about the company's future prospects compared to unplanned, open market sales. Such plans are designed to allow insiders to sell shares without being accused of trading on material non-public information.

Stakeholder Impact

• Shareholders may note the reduction in the CEO's direct ownership, but the pre-planned nature of the sale under a 10b5-1 plan typically mitigates significant concern.

Key Dates

Recommendation

The sale by CareDx's CEO was executed under a pre-arranged 10b5-1 trading plan, indicating a planned personal financial management action rather than a reaction to new company-specific information. This type of transaction generally has a neutral impact on investment sentiment, supporting a 'hold' recommendation unless other fundamental changes occur.

Keywords

CDNA, CareDx, Insider Trading, Form 4, Stock Sale, CEO, 10b5-1 Plan, Executive Compensation